 | • レポートコード：MRC2210A0084 • 出版社/出版日：Transparency Market Research / 2022年7月 • レポート形態：英文、PDF、219ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥857,660 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,301,660 (USD8,795) | ▷ お問い合わせ |
| Corporate License | ￥1,745,660 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Transparency Market Research社の本調査レポートでは、世界の下肢静脈瘤治療市場規模について調査し、序論、仮定・調査手法、エグゼクティブサマリー、市場概要、キーインサイト、製品別（アブレーション装置、硬化療法/癒着注入用カテーテル/キット、圧迫装置/圧迫帯、その他）分析、治療種類別（静脈アブレーション、硬化療法・癒着剤注射、結紮術/ストリップ、支持療法）分析、疾患別（大伏在型下肢静脈瘤、小伏在型下肢静脈瘤、その他）分析、エンドユーザー別（病院・外科手術センター、専門クリニック、その他）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東/アフリカ）分析、競争状況など、以下の項目を掲載しております。本書では、AngioDynamics,Inc.、Boston Scientific Corporation（BTG International Inc.)、DJO,LLC（Enovis Corporation)、Essity Aktiebolag（publ)（BSN Medical)、F Care Systems NV、Medtronic plc、Miravas（IPSA Group)、Mylan N.V.（Viatris Inc.)、SIGVARIS Group、Teleflex Incorporated、VVT Medical、WONTECH Co.,Ltd.などの企業情報が含まれています。 ・序論 ・仮定・調査手法 ・エグゼクティブサマリー ・市場概要 ・キーインサイト ・世界の下肢静脈瘤治療市場規模：製品別 - 下肢静脈瘤治療用アブレーション装置の市場規模 - 下肢静脈瘤治療用硬化療法/癒着注入用カテーテル/キットの市場規模 - 下肢静脈瘤治療用圧迫装置/圧迫帯の市場規模 - その他製品の市場規模 ・世界の下肢静脈瘤治療市場規模：治療種類別 - 下肢静脈瘤治療用静脈アブレーションの市場規模 - 下肢静脈瘤治療用硬化療法・癒着剤注射の市場規模 - 下肢静脈瘤治療用結紮術/ストリップの市場規模 - 下肢静脈瘤治療用支持療法の市場規模 ・世界の下肢静脈瘤治療市場規模：疾患別 - 大伏在型下肢静脈瘤における市場規模 - 小伏在型下肢静脈瘤における市場規模 - その他疾患の市場規模 ・世界の下肢静脈瘤治療市場規模：エンドユーザー別 - 病院・外科手術センターにおける市場規模 - 専門クリニックにおける市場規模 - その他エンドユーザーの市場規模 ・世界の下肢静脈瘤治療市場規模：地域別 - 北米の下肢静脈瘤治療市場規模 - ヨーロッパの下肢静脈瘤治療市場規模 - アジア太平洋の下肢静脈瘤治療市場規模 - 中南米の下肢静脈瘤治療市場規模 - 中東/アフリカの下肢静脈瘤治療市場規模 ・競争状況 |
Varicose Veins Treatment Market – Scope of Report
TMR’s report on the global Varicose Veins Treatment market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report provides revenue of the global Varicose Veins Treatment market for the period 2017–2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global Varicose Veins Treatment market from 2022 to 2031.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the Varicose Veins Treatment market.
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global Varicose Veins Treatment market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global Varicose Veins Treatment market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global Varicose Veins Treatment market.
The report delves into the competitive landscape of the global Varicose Veins Treatment market. Key players operating in the global Varicose Veins Treatment market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global Varicose Veins Treatment market profiled in this report.
RESEARCH METHODOLOGY
The research methodology will be a combination of exhaustive primary and secondary research to analyze the market Varicose Veins Treatment.
Secondary Research
Secondary research includes a search of company literature, technical writing, patent data, Internet sources, and statistical data from government websites, trade associations, and agencies. This has proven to be the most reliable, effective, and successful approach for obtaining precise data, capturing industry participants’ insights, and recognizing business opportunities.
Secondary research sources that we typically refer, but are not limited to:
Company websites, presentations, annual reports, white papers, technical paper, product brochure
Internal and external proprietary databases and relevant patents
National government documents, statistical databases, and market reports
News articles, press releases, and webcasts specific to companies operating in the market
Specific Secondary Sources:
Industry Sources:
WorldWideScience.org
Elsevier, Inc.
National Institutes of Health (NIH)
PubMed
NCBI
Department of Health Care Service
Trade Data Sources
Trade Map
UN Comtrade
Trade Atlas
Company Information
OneSource Business Browser
Hoover’s
Factiva
Bloomberg
Mergers & Acquisitions
Thomson Mergers & Acquisitions
MergerStat
Profound
Primary Research
During the course of research, we conduct in-depth interviews and discussions with a wide range of key industry participants and opinion leaders. Primary research represents bulk of research efforts, supplemented by extensive secondary research.
We conduct primary interviews on the ongoing basis with industry participants and commentators to validate data and analysis. A typical research interview fulfills the following functions:
Provides first-hand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
Helps in validating and strengthening secondary research findings
Further develops the analysis team’s expertise and market understanding
Primary research involves e-mail interactions, telephonic interviews, as well as face-to-face interviews for each market, category, segment, and sub-segment across geographies
Participants who typically take part in such a process include, but are not limited to:
Industry participants: Marketing/product managers, market intelligence managers, and regional sales managers
Purchasing/Sourcing managers, technical personnel, distributors
Outside experts: Investment bankers, valuation experts, and research analysts specializing in specific markets
Key opinion leaders specializing in different areas corresponding to different industry verticals
List of primary participants, but not limited to:
Advanced Oncotherapy PLC
Danfysik A/S
Hitachi, Ltd.
IBA Worldwide
Mevion Medical Systems, Inc.
Data Triangulation: Information culled from “Secondary & Primary Sources” is cross-checked with “TMR Knowledge Repository”, which is updated every quarter.
Market Estimation: Market size estimations involved in-depth study of product features, technology updates, geographic presence, product demand, sales data (value or volume), historical year-on-year growth, and others. Other approaches were also utilized to derive market size and forecasts. Where no hard data was available, we employed modeling techniques in order to produce comprehensive datasets. A rigorous methodology has been adopted, wherein the available hard data are cross-referenced with the following data types to produce estimates:
Demographic Data: Healthcare expenditure, inflation rates, and others
Industry Indicators: R&D investment, technology stage, and infrastructure, sector growth, and facilities
Market Forecasting: Market forecasts for various segments are derived taking into account drivers, restraints/challenges, and opportunities prevailing in the market and considering advantages/disadvantages of segments/sub-segments over other segments/sub-segments. Business environment, historical sales pattern, unmet needs, competitive intensity, and country-wise surgery data are some of the other pivotal factors, which are considered to derive market forecasts.
レポート目次1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Varicose Veins Treatment Market
4. Market Overview
4.1. Overview
4.2. Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
5. Key Insights
5.1. Key Industry Events
5.2. Epidemiology of Varicose Veins Globally with Key Countries
5.3. Overview of Treatment and Management of Varicose Veins
5.4. COVID-19 Pandemic Impact on Industry (value chain and short/mid/long term impact)
6. Global Varicose Veins Treatment Market Analysis and Forecast, by Product
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value & Volume Forecast, by Product, 2017–2031
6.3.1. Ablation Devices
6.3.1.1. Radiofrequency Ablation/Thermal Ablation
6.3.1.2. Laser Ablation Devices
6.3.1.3. Ultrasound Ablation Devices
6.3.2. Catheters/Kits for Sclerotherapy & Adhesion Injection
6.3.3. Compression Devices/Garments
6.3.4. Others
6.4. Market Attractiveness Analysis, by Product
7. Global Varicose Veins Treatment Market Analysis and Forecast, by Treatment Type
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Treatment Type, 2017–2031
7.3.1. Endovenous Ablation
7.3.2. Sclerotherapy/Adhesion Injection
7.3.3. Ligation/Stripping
7.3.4. Supportive Treatment
7.4. Market Attractiveness Analysis, by Treatment Type
8. Global Varicose Veins Treatment Market Analysis and Forecast, by Disease Type
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by Disease Type, 2017–2031
8.3.1. Greater Saphenous Varicose Veins
8.3.2. Small Saphenous Varicose Veins
8.3.3. Others
8.4. Market Attractiveness Analysis, by Disease Type
9. Global Varicose Veins Treatment Market Analysis and Forecast, by End-user
9.1. Introduction & Definition
9.2. Key Findings/Developments
9.3. Market Value Forecast, by End-user, 2017–2031
9.3.1. Hospitals & Ambulatory Surgical Centers
9.3.2. Specialty Clinics
9.3.3. Others
9.4. Market Attractiveness Analysis, by End-user
10. Global Varicose Veins Treatment Market Analysis and Forecast, by Region
10.1. Key Findings
10.2. Market Value Forecast, by Region
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Market Attractiveness Analysis, by Region
11. North America Varicose Veins Treatment Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value & Volume Forecast, by Product, 2017–2031
11.2.1. Ablation Devices
11.2.1.1. Radiofrequency Ablation/Thermal Ablation
11.2.1.2. Laser Ablation Devices
11.2.1.3. Ultrasound Ablation Devices
11.2.2. Catheters/Kits for Sclerotherapy & Adhesion Injection
11.2.3. Compression Devices/Garments
11.2.4. Others
11.3. Market Value Forecast, by Treatment Type, 2017–2031
11.3.1. Endovenous Ablation
11.3.2. Sclerotherapy/Adhesion Injection
11.3.3. Ligation/Stripping
11.3.4. Supportive Treatment
11.4. Market Value Forecast, by Disease Type, 2017–2031
11.4.1. Greater Saphenous Varicose Veins
11.4.2. Small Saphenous Varicose Veins
11.4.3. Others
11.5. Market Value Forecast, by End-user, 2017–2031
11.5.1. Hospitals & Ambulatory Surgical Centers
11.5.2. Specialty Clinics
11.5.3. Others
11.6. Market Value Forecast, by Country, 2017–2031
11.6.1. U.S.
11.6.2. Canada
11.7. Market Attractiveness Analysis
11.7.1. By Product
11.7.2. By Treatment Type
11.7.3. By Disease Type
11.7.4. By End-user
11.7.5. By Country
12. Europe Varicose Veins Treatment Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value & Volume Forecast, by Product, 2017–2031
12.2.1. Ablation Devices
12.2.1.1. Radiofrequency Ablation/Thermal Ablation
12.2.1.2. Laser Ablation Devices
12.2.1.3. Ultrasound Ablation Devices
12.2.2. Catheters/Kits for Sclerotherapy & Adhesion Injection
12.2.3. Compression Devices/Garments
12.2.4. Others
12.3. Market Value Forecast, by Treatment Type, 2017–2031
12.3.1. Endovenous Ablation
12.3.2. Sclerotherapy/Adhesion Injection
12.3.3. Ligation/Stripping
12.3.4. Supportive Treatment
12.4. Market Value Forecast, by Disease Type, 2017–2031
12.4.1. Greater Saphenous Varicose Veins
12.4.2. Small Saphenous Varicose Veins
12.4.3. Others
12.5. Market Value Forecast, by End-user, 2017–2031
12.5.1. Hospitals & Ambulatory Surgical Centers
12.5.2. Specialty Clinics
12.5.3. Others
12.6. Market Value Forecast, by Country/Sub-region, 2017–2031
12.6.1. Germany
12.6.2. U.K.
12.6.3. France
12.6.4. Italy
12.6.5. Spain
12.6.6. Rest of Europe
12.7. Market Attractiveness Analysis
12.7.1. By Product
12.7.2. By Treatment Type
12.7.3. By Disease Type
12.7.4. By End-user
12.7.5. By Country/Sub-region
13. Asia Pacific Varicose Veins Treatment Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value & Volume Forecast, by Product, 2017–2031
13.2.1. Ablation Devices
13.2.1.1. Radiofrequency Ablation/Thermal Ablation
13.2.1.2. Laser Ablation Devices
13.2.1.3. Ultrasound Ablation Devices
13.2.2. Catheters/Kits for Sclerotherapy & Adhesion Injection
13.2.3. Compression Devices/Garments
13.2.4. Others
13.3. Market Value Forecast, by Treatment Type, 2017–2031
13.3.1. Endovenous Ablation
13.3.2. Sclerotherapy/Adhesion Injection
13.3.3. Ligation/Stripping
13.3.4. Supportive Treatment
13.4. Market Value Forecast, by Disease Type, 2017–2031
13.4.1. Greater Saphenous Varicose Veins
13.4.2. Small Saphenous Varicose Veins
13.4.3. Others
13.5. Market Value Forecast, by End-user, 2017–2031
13.5.1. Hospitals & Ambulatory Surgical Centers
13.5.2. Specialty Clinics
13.5.3. Others
13.6. Market Value Forecast, by Country/Sub-region, 2017–2031
13.6.1. China
13.6.2. Japan
13.6.3. India
13.6.4. Australia & New Zealand
13.6.5. Rest of Asia Pacific
13.7. Market Attractiveness Analysis
13.7.1. By Product
13.7.2. By Treatment Type
13.7.3. By Disease Type
13.7.4. By End-user
13.7.5. By Country/Sub-region
14. Latin America Varicose Veins Treatment Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value & Volume Forecast, by Product, 2017–2031
14.2.1. Ablation Devices
14.2.1.1. Radiofrequency Ablation/Thermal Ablation
14.2.1.2. Laser Ablation Devices
14.2.1.3. Ultrasound Ablation Devices
14.2.2. Catheters/Kits for Sclerotherapy & Adhesion Injection
14.2.3. Compression Devices/Garments
14.2.4. Others
14.3. Market Value Forecast, by Treatment Type, 2017–2031
14.3.1. Endovenous Ablation
14.3.2. Sclerotherapy/Adhesion Injection
14.3.3. Ligation/Stripping
14.3.4. Supportive Treatment
14.4. Market Value Forecast, by Disease Type, 2017–2031
14.4.1. Greater Saphenous Varicose Veins
14.4.2. Small Saphenous Varicose Veins
14.4.3. Others
14.5. Market Value Forecast, by End-user, 2017–2031
14.5.1. Hospitals & Ambulatory Surgical Centers
14.5.2. Specialty Clinics
14.5.3. Others
14.6. Market Value Forecast, by Country/Sub-region, 2017–2031
14.6.1. Brazil
14.6.2. Mexico
14.6.3. Rest of Latin America
14.7. Market Attractiveness Analysis
14.7.1. By Product
14.7.2. By Treatment Type
14.7.3. By Disease Type
14.7.4. By End-user
14.7.5. By Country/Sub-region
15. Middle East & Africa Varicose Veins Treatment Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value & Volume Forecast, by Product, 2017–2031
15.2.1. Ablation Devices
15.2.1.1. Radiofrequency Ablation/Thermal Ablation
15.2.1.2. Laser Ablation Devices
15.2.1.3. Ultrasound Ablation Devices
15.2.2. Catheters/Kits for Sclerotherapy & Adhesion Injection
15.2.3. Compression Devices/Garments
15.2.4. Others
15.3. Market Value Forecast, by Treatment Type, 2017–2031
15.3.1. Endovenous Ablation
15.3.2. Sclerotherapy/Adhesion Injection
15.3.3. Ligation/Stripping
15.3.4. Supportive Treatment
15.4. Market Value Forecast, by Disease Type, 2017–2031
15.4.1. Greater Saphenous Varicose Veins
15.4.2. Small Saphenous Varicose Veins
15.4.3. Others
15.5. Market Value Forecast, by End-user, 2017–2031
15.5.1. Hospitals & Ambulatory Surgical Centers
15.5.2. Specialty Clinics
15.5.3. Others
15.6. Market Value Forecast, by Country/Sub-region, 2017–2031
15.6.1. GCC Countries
15.6.2. South Africa
15.6.3. Rest of Middle East & Africa
15.7. Market Attractiveness Analysis
15.7.1. By Product
15.7.2. By Treatment Type
15.7.3. By Disease Type
15.7.4. By End-user
15.7.5. By Country/Sub-region
16. Competition Landscape
16.1. Market Player – Competition Matrix (by tier and size of companies)
16.2. Market Share Analysis/Ranking, by Company, 2021
16.3. Company Profiles
16.3.1. AngioDynamics, Inc.
16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.1.2. Product Portfolio
16.3.1.3. Financial Overview
16.3.1.4. SWOT Analysis
16.3.1.5. Strategic Overview
16.3.2. Boston Scientific Corporation (BTG International Inc.)
16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.2.2. Product Portfolio
16.3.2.3. Financial Overview
16.3.2.4. SWOT Analysis
16.3.2.5. Strategic Overview
16.3.3. DJO, LLC (Enovis Corporation)
16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.3.2. Product Portfolio
16.3.3.3. Financial Overview
16.3.3.4. SWOT Analysis
16.3.3.5. Strategic Overview
16.3.4. Essity Aktiebolag (publ) (BSN Medical)
16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.4.2. Product Portfolio
16.3.4.3. Financial Overview
16.3.4.4. SWOT Analysis
16.3.4.5. Strategic Overview
16.3.5. F Care Systems NV
16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.5.2. Product Portfolio
16.3.5.3. SWOT Analysis
16.3.5.4. Strategic Overview
16.3.6. Medtronic plc
16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.6.2. Product Portfolio
16.3.6.3. Financial Overview
16.3.6.4. SWOT Analysis
16.3.6.5. Strategic Overview
16.3.7. Miravas (IPSA Group)
16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.7.2. Product Portfolio
16.3.7.3. SWOT Analysis
16.3.7.4. Strategic Overview
16.3.8. Mylan N.V. (Viatris Inc.)
16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.8.2. Product Portfolio
16.3.8.3. Financial Overview
16.3.8.4. SWOT Analysis
16.3.8.5. Strategic Overview
16.3.9. SIGVARIS Group
16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.9.2. Product Portfolio
16.3.9.3. SWOT Analysis
16.3.9.4. Strategic Overview
16.3.10. Teleflex Incorporated
16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.10.2. Product Portfolio
16.3.10.3. Financial Overview
16.3.10.4. SWOT Analysis
16.3.10.5. Strategic Overview
16.3.11. VVT Medical
16.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.11.2. Product Portfolio
16.3.11.3. SWOT Analysis
16.3.11.4. Strategic Overview
16.3.12. WONTECH Co., Ltd.
16.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.12.2. Product Portfolio
16.3.12.3. SWOT Analysis
Table 01: Global Varicose Veins Treatment Market Value (US$ Mn） Forecast, by Product, 2017–2031
Table 02: Global Varicose Veins Treatment Market Volume (Units） Forecast, by Product, 2017–2031
Table 03: Global Varicose Veins Treatment Market Value (US$ Mn） Forecast, by Ablation Devices, 2017–2031
Table 04: Global Varicose Veins Treatment Market Volume (Units） Forecast, by Ablation Devices, 2017–2031
Table 05: Global Varicose Veins Treatment Market Value (US$ Mn） Forecast, by Treatment Type, 2017–2031
Table 06: Global Varicose Veins Treatment Market Value (US$ Mn） Forecast, by Disease Type, 2017–2031
Table 07: Global Varicose Veins Treatment Market Value (US$ Mn） Forecast, by End-user, 2017–2031
Table 08: Global Varicose Veins Treatment Market Value (US$ Mn） Forecast, by Region, 2017–2031
Table 09: North America Varicose Veins Treatment Market Value (US$ Mn） Forecast, by Country, 2017–2031
Table 10: North America Varicose Veins Treatment Market Value (US$ Mn） Forecast, by Product, 2017–2031
Table 11: North America Varicose Veins Treatment Market Volume (Units） Forecast, by Product, 2017–2031
Table 12: North America Varicose Veins Treatment Market Value (US$ Mn） Forecast, by Ablation Devices, 2017–2031
Table 13: North America Varicose Veins Treatment Market Volume (Units） Forecast, by Ablation Devices, 2017–2031
Table 14: North America Varicose Veins Treatment Market Value (US$ Mn） Forecast, by Treatment Type, 2017–2031
Table 15: North America Varicose Veins Treatment Market Value (US$ Mn） Forecast, by Disease Type, 2017–2031
Table 16: North America Varicose Veins Treatment Market Value (US$ Mn） Forecast, by End-user, 2017–2031
Table 17: Europe Varicose Veins Treatment Market Value (US$ Mn） Forecast, by Country/Sub-region, 2017–2031
Table 18: Europe Varicose Veins Treatment Market Value (US$ Mn） Forecast, by Product, 2017–2031
Table 19: Europe Varicose Veins Treatment Market Volume (Units） Forecast, by Product, 2017–2031
Table 20: Europe Varicose Veins Treatment Market Value (US$ Mn） Forecast, by Ablation Devices, 2017–2031
Table 21: Europe Varicose Veins Treatment Market Volume (Units） Forecast, by Ablation Devices, 2017–2031
Table 22: Europe Varicose Veins Treatment Market Value (US$ Mn） Forecast, by Treatment Type, 2017–2031
Table 23: Europe Varicose Veins Treatment Market Value (US$ Mn） Forecast, by Disease Type, 2017–2031
Table 24: Europe Varicose Veins Treatment Market Value (US$ Mn） Forecast, by End-user, 2017–2031
Table 25: Asia Pacific Varicose Veins Treatment Market Value (US$ Mn） Forecast, by Country/Sub-region, 2017–2031
Table 26: Asia Pacific Varicose Veins Treatment Market Value (US$ Mn） Forecast, by Product, 2017–2031
Table 27: Asia Pacific Varicose Veins Treatment Market Volume (Units） Forecast, by Product, 2017–2031
Table 28: Asia Pacific Varicose Veins Treatment Market Value (US$ Mn） Forecast, by Ablation Devices, 2017–2031
Table 29: Asia Pacific Varicose Veins Treatment Market Volume (Units） Forecast, by Ablation Devices, 2017–2031
Table 30: Asia Pacific Varicose Veins Treatment Market Value (US$ Mn） Forecast, by Treatment Type, 2017–2031
Table 31: Asia Pacific Varicose Veins Treatment Market Value (US$ Mn） Forecast, by Disease Type, 2017–2031
Table 32: Asia Pacific Varicose Veins Treatment Market Value (US$ Mn） Forecast, by End-user, 2017–2031
Table 33: Latin America Varicose Veins Treatment Market Value (US$ Mn） Forecast, by Country/Sub-region, 2017–2031
Table 34: Latin America Varicose Veins Treatment Market Value (US$ Mn） Forecast, by Product, 2017–2031
Table 35: Latin America Varicose Veins Treatment Market Volume (Units） Forecast, by Product, 2017–2031
Table 36: Latin America Varicose Veins Treatment Market Value (US$ Mn） Forecast, by Ablation Devices, 2017–2031
Table 37: Latin America Varicose Veins Treatment Market Volume (Units） Forecast, by Ablation Devices, 2017–2031
Table 38: Latin America Varicose Veins Treatment Market Value (US$ Mn） Forecast, by Treatment Type, 2017–2031
Table 39: Latin America Varicose Veins Treatment Market Value (US$ Mn） Forecast, by Disease Type, 2017–2031
Table 40: Latin America Varicose Veins Treatment Market Value (US$ Mn） Forecast, by End-user, 2017–2031
Table 41: Middle East & Africa Varicose Veins Treatment Market Value (US$ Mn） Forecast, by Country/Sub-region, 2017–2031
Table 42: Middle East & Africa Varicose Veins Treatment Market Value (US$ Mn） Forecast, by Product, 2017–2031
Table 43: Middle East & Africa Varicose Veins Treatment Market Volume (Units） Forecast, by Product, 2017–2031
Table 44: Middle East & Africa Varicose Veins Treatment Market Value (US$ Mn） Forecast, by Ablation Devices, 2017–2031
Table 45: Middle East & Africa Varicose Veins Treatment Market Volume (Units） Forecast, by Ablation Devices, 2017–2031
Table 46: Middle East & Africa Varicose Veins Treatment Market Value (US$ Mn） Forecast, by Treatment Type, 2017–2031
Table 47: Middle East & Africa Varicose Veins Treatment Market Value (US$ Mn） Forecast, by Disease Type, 2017–2031
Table 48: Middle East & Africa Varicose Veins Treatment Market Value (US$ Mn） Forecast, by End-user, 2017–2031